V. Raja Solomon

4.7k total citations · 2 hit papers
124 papers, 3.8k citations indexed

About

V. Raja Solomon is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, V. Raja Solomon has authored 124 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Organic Chemistry, 55 papers in Molecular Biology and 18 papers in Computational Theory and Mathematics. Recurrent topics in V. Raja Solomon's work include Synthesis and biological activity (44 papers), Quinazolinone synthesis and applications (35 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (27 papers). V. Raja Solomon is often cited by papers focused on Synthesis and biological activity (44 papers), Quinazolinone synthesis and applications (35 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (27 papers). V. Raja Solomon collaborates with scholars based in India, Canada and Australia. V. Raja Solomon's co-authors include Hoyun Lee, V. Alagarsamy, Changkun Hu, S. B. Katti, Kumkum Srivastava, Sunil Puri, W. Haq, G. Saravanan, K. Chitra and Sheetal Pundir and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

V. Raja Solomon

116 papers receiving 3.7k citations

Hit Papers

Quinoline as a Privileged Scaffold in Cancer Drug Discovery 2011 2026 2016 2021 2011 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quinoline as a Privileged Scaffold in Cancer Drug Discovery
    2011 516 citations V. Raja Solomon et al. profile →
  2. Drug Repurposing: An Effective Tool in Modern Drug Discovery
    2023 104 citations V. Alagarsamy, V. Raja Solomon et al. profile →

Peers

V. Raja Solomon
Silvia Schenone Italy
Jörg Rademann Germany
Jean Leandro dos Santos Brazil
Vladimı́r Kryštof Czechia
Basappa Basappa India
Giovanni Sorba Italy
Ao Zhang China
Kateřina Vávrová Czechia
Bin Yu China
Hong‐Min Liu China
Silvia Schenone Italy
V. Raja Solomon
Citations per year, relative to V. Raja Solomon V. Raja Solomon (= 1×) peers Silvia Schenone

Countries citing papers authored by V. Raja Solomon

Since Specialization
Citations

This map shows the geographic impact of V. Raja Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Raja Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Raja Solomon more than expected).

Fields of papers citing papers by V. Raja Solomon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Raja Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Raja Solomon. The network helps show where V. Raja Solomon may publish in the future.

Co-authorship network of co-authors of V. Raja Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of V. Raja Solomon. A scholar is included among the top collaborators of V. Raja Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Raja Solomon. V. Raja Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Solomon, V. Raja, et al.. (2025). Optimizing processes and unveiling the therapeutic potential of electrospun gelatin nanofibers for biomedical applications. Journal of Materials Chemistry B. 13(18). 5202–5225. 4 indexed citations
3.
Bisht, Shradha, et al.. (2025). Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes. Metabolic Brain Disease. 40(3). 132–132. 2 indexed citations
4.
Krishnan, Manikandan, et al.. (2024). Liquid chromatography–tandem mass spectrometry determination of bumetanide in human plasma and application to a clinical pharmacokinetic study. Biomedical Chromatography. 38(4). e5825–e5825. 1 indexed citations
5.
6.
Krishnan, Manikandan, et al.. (2024). Bioanalytical Method for Estimation of Nitrofurantoin in Human Plasma Using Liquid Chromatography–Tandem Mass Spectrometry. Journal of Analytical Chemistry. 79(8). 1108–1120.
7.
Alagarsamy, V., et al.. (2024). Molecular Docking and In Silico ADME(T) Evaluation of Selective Phytochemical Inhibitors of VEGF2 Target for the Treatment of Diabetic Retinopathy. Current Chemical Biology. 18(3). 113–128. 1 indexed citations
8.
9.
Krishnan, Manikandan, et al.. (2023). Recent Developments in Electrospun Nanofibers as Delivery of Phytoconstituents for Wound Healing. MDPI (MDPI AG). 2(1). 148–171. 19 indexed citations
10.
Alagarsamy, V., et al.. (2023). Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics. Journal of Biomolecular Structure and Dynamics. 41(20). 10678–10689. 5 indexed citations
11.
Alwani, Saniya, et al.. (2023). Biodistribution of nanodiamonds is determined by surface functionalization. Diamond and Related Materials. 137. 110071–110071. 4 indexed citations
12.
Alizadeh, Elahe, Khan Behlol Ayaz Ahmed, V. Raja Solomon, et al.. (2021). 89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo. Cancers. 13(3). 560–560. 9 indexed citations
13.
Solomon, V. Raja, Elahe Alizadeh, Wendy Bernhard, et al.. (2020). Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer. Scientific Reports. 10(1). 18549–18549. 10 indexed citations
14.
Pundir, Sheetal, et al.. (2015). VR23: A Quinoline–Sulfonyl Hybrid Proteasome Inhibitor That Selectively Kills Cancer via Cyclin E–Mediated Centrosome Amplification. Cancer Research. 75(19). 4164–4175. 27 indexed citations
15.
Solomon, V. Raja, Changkun Hu, & Hoyun Lee. (2010). Design and synthesis of chloroquine analogs with anti-breast cancer property. European Journal of Medicinal Chemistry. 45(9). 3916–3923. 39 indexed citations
16.
Hu, Changkun, V. Raja Solomon, Pablo Cano, & Hoyun Lee. (2009). A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells. European Journal of Medicinal Chemistry. 45(2). 705–709. 29 indexed citations
17.
18.
Solomon, V. Raja, W. Haq, Martin J. Smilkstein, et al.. (2008). Synthesis and Antimalarial Activity of Novel Side Chain Modified Antimalarial Agents Derived from 4-Aminoquinoline. Medicinal Chemistry. 4(5). 446–456. 11 indexed citations
19.
20.
Alagarsamy, V., et al.. (2003). Antihiv and antibacterial activities of 2-substituted thiadiazolo quinazolines. Indian Journal of Pharmaceutical Sciences. 65(3). 293–296. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Schenone Breakdown of academic impact, for papers by Jörg Rademann Breakdown of academic impact, for papers by Jean Leandro dos Santos Breakdown of academic impact, for papers by Vladimı́r Kryštof Breakdown of academic impact, for papers by Basappa Basappa Breakdown of academic impact, for papers by Giovanni Sorba Breakdown of academic impact, for papers by Ao Zhang Breakdown of academic impact, for papers by Kateřina Vávrová Breakdown of academic impact, for papers by Bin Yu Breakdown of academic impact, for papers by Hong‐Min Liu
Rankless by CCL
2026